TOPLINE: Higher persistent PSA levels post-surgery were linked to increased mortality risk, with 8-year prostate cancer–specific mortality reaching 13.86% for a prostate-specific antigen (PSA) ≥ 1 ng/mL. METHODOLOGY: The conventional 1.5-month to 2.0-month time interval following radical prostatectomy (RP) for assessing persistent PSA remained questionable for accuracy…
Leave a Comment Leave a Comment
